Safety and efficacy of rozanolixizumab in patients with generalised myasthenia gravis (MycarinG): a randomised, double-blind, placebo-controlled, adaptive phase 3 study - Concepedia

Concepedia

Publication | Closed Access

Safety and efficacy of rozanolixizumab in patients with generalised myasthenia gravis (MycarinG): a randomised, double-blind, placebo-controlled, adaptive phase 3 study

227

Citations

21

References

2023

Year

Vera Bril, Artur Drużdż, Julian Großkreutz, Ali A. Habib, Renato Mantegazza, Sabrina Sacconi, Kimiaki Utsugisawa, John Vissing, Tuan Vu, Marion Boehnlein,

The Lancet Neurology

Clinical TrialsGeneralised Myasthenia GravisPharmacotherapyMedicineAnesthesiologyAdaptive Phase 3

References

	Year	Citations

Page 1